| Name | Title | Contact Details |
|---|
BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we`ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.
Life Star Response of Maryland is a Lutherville Timonium, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Saint Joseph Medical Center is a Polson, MT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.
Avanti Hospitals currently owns and operates four acute care hospitals: East Los Angeles Doctors Hospital, Memorial Hospital of Gardena, Community Hospital of Huntington Park, and Coast Plaza Hospital, all located near Los Angeles, California. Our mission is to provide affordable, high quality healthcare services to our community with consistency and compassion. Avanti is committed to cooperating with and supporting the long-term needs and objectives of each community we serve. We understand the impact we have on our communities and the potential to improve overall health. We have worked hard to establish a reputation of quality and trust in our communities, including local physicians and governments. At each of our hospitals, we seek to implement community support through a variety of initiatives that are specific to each individual community. With nearly 2,000 employees and over 775 physicians, the Avanti team is committed to delivering the highest quality care to our patients through a broad range of medical services. We also continue to add new programs and technology to meet the meet the growing needs of the communities we serve.